Results 71 to 80 of about 9,346,677 (199)

Placebo, nocebo, and care effect [PDF]

, 2016
Placebo, nocebo and care effect by Mathilde Alice Krähenbühl. Placebo, nocebo and care responses are an interesting challenge of eastern medicine. From their definitions and the problems arising through them, to their usage in randomized controlled ...
Krähenbühl, Mathilde Alice
core   +1 more source

Placebo and nocebo effects in the neurological practice

Arquivos de Neuro-Psiquiatria, 2015
Knowledge of placebo and nocebo effects is essential to identify their influence on the results in clinical practice and clinical trials, and thereby properly interpret their results.
Caroline Bittar, Osvaldo J.M. Nascimento
doaj   +1 more source

Nocebo hyperalgesia: contributions of social observation and body-related cognitive styles

, 2016
Elisabeth Vögtle,1 Birgit Kröner-Herwig,1 Antonia Barke21Department of Clinical Psychology and Psychotherapy, Georg-Elias-Müller-Institute for Psychology, University of Göttingen, Göttingen, 2Department of Psychology, Division of
Vögtle E, Kröner-Herwig B, Vögtle, Elisabeth, Barke, Antonia, Barke A, Kroener-Herwig, Birgit   +5 more
core   +1 more source

Short‐Term Effect of Negative Verbal Language Versus Positive Verbal Language on Physical and Functional Capacity and Pain in People With Chronic Primary Low Back Pain

European Journal of Pain, Volume 30, Issue 8, September 2026.
ABSTRACT Background Low back pain (LBP) is the leading cause of years lived with disability. While education is recommended by most guidelines, the type of language used can lead to a placebo or nocebo effect. This study aims to compare the short‐term effect of negative language versus positive language on physical and functional capacity in ...
Yves Schwendenmann, Pierre‐Antoine Palacios, Martin Descarreaux, Andrée‐Anne Marchand   +3 more
wiley   +1 more source

Is Role Conflict Creating the Nocebo Effect on Accounting Educators? [PDF]

, 2020
Opposite to the placebo effect is the nocebo effect (Colagiuri 2019), where negative expectations can create poor results. In this research, workloads of Accounting Educators are reviewed using the Role theory lens to determine if heavy workloads causing
Northcote, Maria T., Long, Warrick R., Williams, Anthony, Barnes, Lisa   +3 more
core   +1 more source

Comparative Effectiveness Analysis of Phase 3 Clinical Trials in Moderately to Severely Active Inflammatory Bowel Disease Reveals Increased Harm From Placebo and Challenges Equipoise

JCC Plus, Volume 1, Issue 5, September 2026.
Across 47 Phase 3 trials in Crohn's disease and ulcerative colitis, placebo exposure was associated with measurable harm. Disease exacerbation events showed the greatest excess risk, with one additional exacerbation occurring for every 8–13 patients assigned to placebo rather than active therapy.
Joëlle St‐Pierre, Zachary D. Fine, Evan N. Fear, Jeremy A. Klein, Natalie K. Choi, David T. Rubin   +5 more
wiley   +1 more source

The Nocebo Effect in Long-term Disease: a systematic review

, 2023
A pre-registration of a systematic review which aims to look at the nocebo effect in long-term ...
Emma Palmer, Billy Church, Pankaj Gutpa, Ainslea Cross   +3 more
core   +1 more source

Is the intention to use sport supplements a predictor of placebo and nocebo responding among athletes? [PDF]

, 2017
Background: Placebo and nocebo effects have been observed in relation to many interventions in sport. Given variance in response, a key question is whether individual difference variables identify likely ‘responders.’ Hypothetically, such a variable ...
Beedie, C., Hurst, P., Coleman, D., Foad, A.   +3 more
core  

Improving the Understanding and Measurement of the Nocebo Effect

, 2021
Unexplained adverse reactions are a common result of medical treatments and interventions. These responses are often suggestive of the nocebo effect but to date little research has examined the underlying environment of real-life health events that ...
MacKrill, Kate Madeleine
core  

Lost in Translation: Why Biologic Therapies for Intervertebral Disc Degeneration and Low Back Pain Have Not Reached the Clinic (Yet)

JOR SPINE, Volume 9, Issue 3, September 2026.
From preclinical promise to clinical translation in intervertebral disc degeneration (IDD). Robust preclinical evidence supports a range of biologic therapies, with consistent improvements in imaging, extracellular matrix composition, inflammation, and behavior.
Luca Ambrosio, Jordy Schol, Clara Ruiz‐Fernandez, Vincenzo Denaro, Gianluca Vadalà, Daisuke Sakai   +5 more
wiley   +1 more source